This free half-day event will feature three panels of subject matter experts discussing the latest advancements in ...
C2N Diagnostics LLC, a St. Louis-based biotechnology firm that developed blood-based tests for Alzheimer's and other neurological diseases, has received a grant from The Michael J. Fox Foundation for ...
The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify ...
Spanish drugmaker Grifols has been awarded a $21 million grant from the Michael J Fox Foundation to support a pilot study to ...
Fox Foundation for Parkinson’s Research (MJFF) to identify plasma-based biomarkers that could indicate a person’s likelihood of developing Parkinson’s disease (PD) many years before clinical ...
Fox Foundation for Parkinson’s Research (MJFF). The project, called Chronos-PD, will be spearheaded by Grifols’ subsidiary Alkahest, the company said in a Jan. 14 release. The MJFF’s funds ...
News Medical on MSN3d
Grifols receives grant for early Parkinson's disease biomarker discoveryGrifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...
Grifols has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to identify plasma-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback